(Q79886528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

26 December 2019

main subject

1 reference

Shigenori Kanazawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kazuyuki Yamaguchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yoshimi Kinoshita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yutaka Komiyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mikiko Muramatsu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shosaku Nomura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

12 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

719-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-006-0120-x

26 December 2019

exact match

0 references

cites work

Interleukin-2 receptors in pulmonary adenocarcinoma tissue

1 reference

12 December 2020

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

12 December 2020

[The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients]

1 reference

12 December 2020

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

12 December 2020

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

1 reference

12 December 2020

The clinical significance of serum soluble interleukin-2 receptors in lung cancer

1 reference

12 December 2020

Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75.

1 reference

12 December 2020

Interleukin 2 receptor in patients with localized and systemic parasitic diseases

1 reference

12 December 2020

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.

1 reference

12 December 2020

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

1 reference

12 December 2020

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

1 reference

12 December 2020

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Toward the primary prevention of cancer

1 reference

12 December 2020

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

12 December 2020

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

1 reference

12 December 2020

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

12 December 2020

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes

1 reference

12 December 2020

The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Gefitinib has the potential of activating cell immunity against malignant cells

1 reference

12 December 2020

Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response.

1 reference

12 December 2020

Gefitinib affects functions of platelets and blood vessels via changes in prostanoids balance

1 reference

12 December 2020

Surgical treatment of bronchogenic carcinoma: the importance of staging in evaluating late survival.

1 reference

12 December 2020

Biomarkers and IL-2R in lung cancer

1 reference

12 December 2020

Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy

1 reference

12 December 2020

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

1 reference

12 December 2020

Serum Soluble Interleukin-2 Receptor Levels in Patients with Breast Cancer

1 reference

12 December 2020

10.1007/S00432-006-0120-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16835747%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference